Dental Implants
0
Pipeline Programs
3
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Geistlich PharmaSwitzerland - Root
2 programsConnective Tissue GraftN/A1 trial
Immediate implant and socket preservationN/A1 trial
Active Trials
City TherapeuticsMA - Cambridge
1 programCombining a strip free gingival graftN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
City TherapeuticsCombining a strip free gingival graft
Orchard TherapeuticsOSSIX Volumax
Geistlich PharmaConnective Tissue Graft
Geistlich PharmaImmediate implant and socket preservation
Clinical Trials (4)
Total enrollment: 36 patients across 4 trials
Augmentation of Peri-implant Keratinized Mucosa Using a Combination of Free Gingival Graft Strip With Platelet-Rich Fibrin
Start: Dec 2025Est. completion: Jul 2026
N/ARecruiting
Retrospective Case Series - OSSIX Volumax Collagen Xenograft Scaffolding
Start: Nov 2023Est. completion: Feb 2024
N/AUnknown
CTG vs VCMX for Peri-implant Soft Tissue Thickness
Start: Jan 2022Est. completion: Apr 202536 patients
N/ACompleted
Study on Immediate Loading of Immediately Placed Single Implants.
Start: Jun 2010Est. completion: Jun 20110
N/AWithdrawn
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 36 patients
3 companies competing in this space